SKYVEC Trademark
Serial Number: 50017135
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Joshua M. Gerben Gerben Perrott, PLLC
1050 Connecticut Ave. NW Suite 500
Washington, DC 20036
United States
Trademark Details
Filing Date
July 28, 2026
Registration Date
Not Registered
Goods & Services
Custom manufacture of biopharmaceuticals; Custom manufacture of viral vectors and viral vector-based pharmaceutical products for use in gene therapy, cell therapy, and advanced therapy medicinal products; Custom manufacture of viral vectors, cell banks, viral banks, related biological materials, and pharmaceutical products for use in preclinical, clinical, and commercial gene therapy, cell therapy, vaccines, and oncolytic viral therapies; Manufacturing services for others in the field of viral vectors, cell banks, viral banks, related biological materials, and pharmaceutical products for use in preclinical, clinical, and commercial gene therapy, cell therapy, vaccines, and oncolytic viral therapies
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceuticals for cell and gene therapies; Testing of pharmaceuticals for cell and gene therapies; Laboratory services for producing viral vectors for pharmaceutical use; Laboratory services for biomanufacturing viral vectors for pharmaceutical use; Laboratory services for biomanufacturing vaccines, oncolytic viral therapies, and advanced therapy medicinal products; Laboratory services for the production of pharmaceuticals in the nature of developing, testing, and characterizing cell banks and viral banks; Scientific and technological services, namely, development of assays, cell lines, cell banks, viral banks, analytical testing, processes, product characterization, and manufacturing, quality, and regulatory testing in the field of viral vectors, gene therapy, cell therapy, vaccines, oncolytic viral therapies, and advanced therapy medicinal products; Technological planning and consulting services in the field of viral vector development and manufacturing